Answer
Rasburicase (Fasturtec) should be used during pregnancy only if strictly necessary because teratogenic effects cannot be ruled out and there are no data in pregnant women; it is not recommended for women of childbearing potential who are not using contraception.
Sources for this answer
- Fasturtec 1.5 mg/ml powder and solvent for concentrate for solution for infusionSANOFI · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 23Document updated
Sources checked